Preventing atherosclerotic events with aspirin.
作者信息
Cleland John G F
机构信息
Department of Cardiology, Castle Hill Hospital, University of Hull, Kingston upon Hull HU16 5JQ.
出版信息
BMJ. 2002 Jan 12;324(7329):103-5. doi: 10.1136/bmj.324.7329.103.
Abstract
摘要
相似文献
1
Preventing atherosclerotic events with aspirin.
BMJ. 2002 Jan 12;324(7329):103-5. doi: 10.1136/bmj.324.7329.103.
2
[Acetylsalicylic acid in the primary and secondary prevention of vascular disease].
Internist (Berl). 2010 Oct;51(10):1330, 1332. doi: 10.1007/s00108-010-2723-1.
3
Aspirin and the risk of hemorrhagic stroke.
J Fam Pract. 1999 Mar;48(3):169-70.
4
JAMA patient page. Aspirin therapy.
JAMA. 2013 Apr 17;309(15):1645. doi: 10.1001/jama.2013.3866.
5
Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses.
Arch Neurol. 2000 Mar;57(3):326-32. doi: 10.1001/archneur.57.3.326.
6
Aspirin and its rivals. As your options increase, your choices get harder.
Harv Mens Health Watch. 2002 Dec;7(5):1-5.
7
Aspirin for first-line heart attack prevention. These is still no consensus; the benefits must be weighed against the risks.
Duke Med Health News. 2014 Nov;20(11):5-6.
8
9
Aspirin, myocardial infarction, and gastrointestinal bleeding.
Lancet. 1999 Feb 20;353(9153):676. doi: 10.1016/s0140-6736(05)75475-1.
10
Aspirin or warfarin: what's best after a heart attack? Risk of bleeding counters warfarin's edge in efficacy.
Health News. 2002 Nov;8(11):3.
引用本文的文献
1
Aspirin Use and Mortality in Two Contemporary US Cohorts.
Epidemiology. 2018 Jan;29(1):126-133. doi: 10.1097/EDE.0000000000000746.
2
Platelets: still a therapeutical target for haemostatic disorders.
Int J Mol Sci. 2014 Oct 7;15(10):17901-19. doi: 10.3390/ijms151017901.
3
Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial.
BMJ. 2008 Sep 1;337:a1198. doi: 10.1136/bmj.a1198.
4
Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
Drugs. 2007;67(7):997-1026. doi: 10.2165/00003495-200767070-00005.
5
Secondary prevention of stroke: a practical guide to drug treatment.
CNS Drugs. 2004;18(4):221-41. doi: 10.2165/00023210-200418040-00003.
6
Cardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicity.
Br J Clin Pharmacol. 2004 Feb;57(2):188-98. doi: 10.1046/j.1365-2125.2003.01979.x.
7
Aspirin for the prevention of cardiovascular events in the elderly.
Drugs Aging. 2003;20(13):999-1010. doi: 10.2165/00002512-200320130-00004.
8
Changes in drug treatment in the elderly between 1971 and 2000.
Eur J Clin Pharmacol. 2003 Nov;59(8-9):637-44. doi: 10.1007/s00228-003-0647-6. Epub 2003 Aug 16.
9
Acute coronary disease Athero-Inflammation: Therapeutic approach.
Thromb J. 2003 Jun 20;1(1):2. doi: 10.1186/1477-9560-1-2.
10
Antiplatelet therapy and atherosclerotic events. Commentary is inaccurate.
BMJ. 2002 Apr 13;324(7342):917.
本文引用的文献
1
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
BMJ. 2002 Jan 12;324(7329):71-86. doi: 10.1136/bmj.324.7329.71.
2
Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors in hypertension or heart failure?
Curr Opin Nephrol Hypertens. 2001 Sep;10(5):625-31. doi: 10.1097/00041552-200109000-00012.
3
Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial.
Lancet. 2000 Apr 15;355(9212):1295-302.
4
Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs.
Gut. 2000 Jan;46(1):27-31. doi: 10.1136/gut.46.1.27.
5
Anticoagulant and antiplatelet therapy in heart failure.
Curr Opin Cardiol. 1997 May;12(3):276-87. doi: 10.1097/00001573-199705000-00009.
6
7
Is aspirin safe for patients with heart failure?
Br Heart J. 1995 Sep;74(3):215-9. doi: 10.1136/hrt.74.3.215.
8
The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group.
Circulation. 1980 Dec;62(6 Pt 2):V79-84.
9
The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group.
Circulation. 1980 Dec;62(6 Pt 2):V85-8.
Zotero 插件